Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.87B |
| FY2017, ended Dec 31, 2017 | $17.4B |
| FY2018, ended Dec 31, 2018 | $16.0B |
| FY2019, ended Dec 31, 2019 | $15.6B |
| FY2020, ended Dec 31, 2020 | $22.2B |
| FY2021, ended Dec 31, 2021 | $44.2B |
| FY2022, ended Dec 31, 2022 | $37.2B |
| FY2023, ended Dec 31, 2023 | $73.6B |
| FY2024, ended Dec 31, 2024 | $139B |
| FY2025, ended Dec 31, 2025 | $165B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $214B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.13B |
| FY2017, ended Dec 31, 2017 | $1.65B |
| FY2018, ended Dec 31, 2018 | $2.15B |
| FY2019, ended Dec 31, 2019 | $2.41B |
| FY2020, ended Dec 31, 2020 | $2.32B |
| FY2021, ended Dec 31, 2021 | $2.95B |
| FY2022, ended Dec 31, 2022 | $4.38B |
| FY2023, ended Dec 31, 2023 | $5.86B |
| FY2024, ended Dec 31, 2024 | $7.00B |
| FY2025, ended Dec 31, 2025 | $9.01B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $184M | $153M |
| FY2017, ended Dec 31, 2017 | $423M | $616M |
| FY2018, ended Dec 31, 2018 | $328M | $479M |
| FY2019, ended Dec 31, 2019 | $860M | $947M |
| FY2020, ended Dec 31, 2020 | $635M | $720M |
| FY2021, ended Dec 31, 2021 | $841M | $951M |
| FY2022, ended Dec 31, 2022 | $1.35B | $448M |
| FY2023, ended Dec 31, 2023 | $2.09B | $2.00B |
| FY2024, ended Dec 31, 2024 | $2.85B | $3.68B |
| FY2025, ended Dec 31, 2025 | $3.51B | $4.25B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.04B | $5.16B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $568M |
| FY2017, ended Dec 31, 2017 | $859M |
| FY2018, ended Dec 31, 2018 | $650M |
| FY2019, ended Dec 31, 2019 | $1.11B |
| FY2020, ended Dec 31, 2020 | $893M |
| FY2021, ended Dec 31, 2021 | $621M |
| FY2022, ended Dec 31, 2022 | $672M |
| FY2023, ended Dec 31, 2023 | $1.94B |
| FY2024, ended Dec 31, 2024 | $2.76B |
| FY2025, ended Dec 31, 2025 | $1.96B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.29B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
No figures for this period in the company’s filings.
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 11.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.14B |
| FY2017, ended Dec 31, 2017 | 1.18B |
| FY2018, ended Dec 31, 2018 | 1.21B |
| FY2019, ended Dec 31, 2019 | 1.22B |
| FY2020, ended Dec 31, 2020 | 1.22B |
| FY2021, ended Dec 31, 2021 | 1.23B |
| FY2022, ended Dec 31, 2022 | 1.23B |
| FY2023, ended Dec 31, 2023 | 1.25B |
| FY2024, ended Dec 31, 2024 | 1.26B |
| FY2025, ended Dec 31, 2025 | 1.26B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.26B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $59.0M | — |
| FY2017, ended Dec 31, 2017 | $0 | $75.4M | — |
| FY2018, ended Dec 31, 2018 | $0 | $91.2M | $15.6M |
| FY2019, ended Dec 31, 2019 | $266M | $101M | — |
| FY2020, ended Dec 31, 2020 | $395M | $137M | — |
| FY2021, ended Dec 31, 2021 | $412M | $187M | — |
| FY2022, ended Dec 31, 2022 | $670M | $231M | $4.05M |
| FY2023, ended Dec 31, 2023 | $112M | $297M | $2.30M |
| FY2024, ended Dec 31, 2024 | $424M | $355M | — |
| FY2025, ended Dec 31, 2025 | $1.60B | $439M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $620M | $502M | — |
Valuation
At current price- Market Cap
- $236B
- P/E
- 58.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 22.4×
- Price / Book
- 15.9×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $10.5B
- Revenue Growth YoY
- 32.6%
- Revenue CAGR 3Y
- 27.1%
- Revenue CAGR 5Y
- 31.2%
- EPS Growth YoY
- 23.9%
- Net Income Growth YoY
- 24.4%
Profitability
Trailing 12 months- Gross Margin
- 63.0%
- Operating Margin
- 43.1%
- Net Margin
- 38.4%
- FCF Margin
- 48.9%
- Return on Equity
- 31.5%
Earnings
Trailing 12 months- Net Income
- $4.04B
- EPS (diluted)
- $3.16
- EBITDA
- $4.64B
- Operating Income
- $4.55B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.29B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $23.7B
- Total Liabilities
- $8.92B
- Shareholders' Equity
- $14.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.31B
- Capital Expenditure
- $151M
- Free Cash Flow
- $5.16B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.60
Every ratio is calculated from the company’s reported figures.